ketoconazole has been researched along with Adenoma, Prostatic in 4 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " As the prostate is an androgen-dependent organ, we investigated the effect of the use of tamsulosin in combination with ketoconazole in cases of acute urinary retention (AUR) due to benign prostatic obstruction (BPO)." | 9.17 | Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial). ( El-Gamal, OM; Elbendary, M; Soliman, MG; Taha, MR; Tawfik, A, 2013) |
| " As the prostate is an androgen-dependent organ, we investigated the effect of the use of tamsulosin in combination with ketoconazole in cases of acute urinary retention (AUR) due to benign prostatic obstruction (BPO)." | 5.17 | Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial). ( El-Gamal, OM; Elbendary, M; Soliman, MG; Taha, MR; Tawfik, A, 2013) |
| "Sections of benign prostatic hyperplasia and prostatic carcinoma from each patient were stained with antibodies to AR and GR using an avidin-biotin peroxidase technique." | 1.29 | Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma. ( Chen, Y; Cidlowski, JA; French, FS; Hall, SH; Hamil, K; Mohler, JL; Sar, M; Wilson, EM, 1996) |
| "Patients with benign prostatic hypertrophy (BPH) were treated with MA (160 mg/day) plus KC (1,200 mg/day) for 7 days." | 1.27 | Effects of androgen blockade with ketoconazole and megestrol acetate on human prostatic protein patterns. ( Albert, J; Geller, J; Liu, J, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elbendary, M | 1 |
| El-Gamal, OM | 1 |
| Soliman, MG | 1 |
| Tawfik, A | 1 |
| Taha, MR | 1 |
| Mohler, JL | 1 |
| Chen, Y | 1 |
| Hamil, K | 1 |
| Hall, SH | 1 |
| Cidlowski, JA | 1 |
| Wilson, EM | 1 |
| French, FS | 1 |
| Sar, M | 1 |
| Liu, J | 2 |
| Albert, J | 2 |
| Geller, J | 2 |
| Fay, W | 1 |
| Berry, CC | 1 |
1 trial available for ketoconazole and Adenoma, Prostatic
| Article | Year |
|---|---|
Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Humans; Ketoconazole; Male; Middle | 2013 |
3 other studies available for ketoconazole and Adenoma, Prostatic
| Article | Year |
|---|---|
Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma.
Topics: Aged; Aminoglutethimide; Epithelial Cells; Humans; Immunohistochemistry; Ketoconazole; Male; Middle | 1996 |
Effects of androgen blockade with ketoconazole and megestrol acetate on human prostatic protein patterns.
Topics: Androgen Antagonists; Androgens; Cell Separation; Electrophoresis, Polyacrylamide Gel; Epithelium; H | 1986 |
Effect of antiandrogen and/or antiestrogen blockade on human prostate epithelial and stromal cell protein synthesis.
Topics: Dihydrotestosterone; Epithelium; Humans; Ketoconazole; Kinetics; Male; Megestrol; Megestrol Acetate; | 1986 |